KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Cvs Health (CVS) Cost of Revenue (2016 - 2025)

Cvs Health's Cost of Revenue history spans 17 years, with the latest figure at -$117.1 billion for Q4 2025.

  • For the quarter ending Q4 2025, Cost of Revenue fell 311.93% year-over-year to -$117.1 billion, compared with a TTM value of $23.1 billion through Dec 2025, down 83.63%, and an annual FY2025 reading of $45.0 billion, down 78.2% over the prior year.
  • Cost of Revenue for Q4 2025 was -$117.1 billion at Cvs Health, down from $57.0 billion in the prior quarter.
  • The five-year high for Cost of Revenue was $144.1 billion in Q4 2022, with the low at -$117.1 billion in Q4 2025.
  • Average Cost of Revenue over 5 years is $32.3 billion, with a median of $35.4 billion recorded in 2021.
  • Year-over-year, Cost of Revenue skyrocketed 388.59% in 2021 and then plummeted 311.93% in 2025.
  • Tracing CVS's Cost of Revenue over 5 years: stood at $74.0 billion in 2021, then soared by 94.71% to $144.1 billion in 2022, then plummeted by 60.15% to $57.4 billion in 2023, then fell by 3.75% to $55.3 billion in 2024, then plummeted by 311.93% to -$117.1 billion in 2025.
  • Per Business Quant, the three most recent readings for CVS's Cost of Revenue are -$117.1 billion (Q4 2025), $57.0 billion (Q3 2025), and $54.0 billion (Q2 2025).